| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA708179 | F | Optimal dose of the compound measured in mg/kg against CDF1 mice bearing L1210 leukemia cells. | Mus musculus | 12 | organism-based format | Scientific Literature | ||
| 2. | ALA708853 | F | Antitumor activity (ip) against CDF1 mice bearing Leukemia L1210 cells | Mus musculus | 14 | organism-based format | Scientific Literature | ||
| 3. | ALA707723 | F | Antitumor activity (ip) against CDF1 mice bearing Leukemia L1210 cells in 6 mice | Mus musculus | 14 | organism-based format | Scientific Literature | ||
| 4. | ALA707612 | F | Optimal dose of the compound measured in mg/kg against BDF1 mice bearing M5076 reticulum cell sarcoma | 1 | organism-based format | Scientific Literature | |||
| 5. | ALA707615 | F | Antitumor activity (ip) against BDF1 mice bearing M5076 reticulum cell sarcoma | 1 | organism-based format | Scientific Literature | |||
| 6. | ALA707616 | F | Antitumor activity (ip) against BDF1 mice bearing M5076 reticulum cell sarcoma | 1 | organism-based format | Scientific Literature | |||
| 7. | ALA733215 | F | Optimal dose in Sarcoma inoculated CFW mice. | Mus musculus | 20 | organism-based format | Scientific Literature | ||
| 8. | ALA735525 | F | Antitumor activity against CFW mice bearing Sarcoma 180 ascites (S180a) following i.p. administration. | Mus musculus | 20 | organism-based format | Scientific Literature | ||
| 9. | ALA746315 | F | Number of surviving CFW mice bearing Sarcoma 180 ascites (S180a) (6 mice treated i.p.) | Mus musculus | 18 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!